{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:00:34Z","timestamp":1772258434045,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.phrs.2024.107525","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T21:11:15Z","timestamp":1732828275000},"page":"107525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Antagonising Yin Yang 1 ameliorates the symptoms of lupus nephritis via modulating T lymphocyte signaling"],"prefix":"10.1016","volume":"210","author":[{"given":"Haoxing","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107525_bib1","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2024.107525_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41584-020-0401-9","article-title":"Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy","volume":"16","author":"Maria","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2024.107525_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: clinical presentations and outcomes in the 21st century","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2024.107525_bib4","first-page":"543","article-title":"Determining treatment response in lupus nephritis","volume":"18","author":"Allison","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phrs.2024.107525_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1063497","article-title":"Mesangial cell: A hub in lupus nephritis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107525_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103182","article-title":"Efficacy and safety of intravenous immunoglobulin in patients with lupus nephritis: a systematic review of the literature","volume":"21","author":"Cajamarca-Bar\u00f3n","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2024.107525_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102871","article-title":"Lupus nephritis: new progress in diagnosis and treatment","volume":"132","author":"Yu","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.phrs.2024.107525_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148000","article-title":"CCL17-producing cDC2s are essential in end-stage lupus nephritis and averted by a parasitic infection","volume":"131","author":"Amo","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107525_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phrs.2024.107525_bib10","article-title":"Therapeutic effects of cationic liposomes on lupus-prone MRL\/lpr mice are mediated via inhibition of TLR4-triggered B-cell activation","volume":"40","author":"Diao","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.phrs.2024.107525_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147334","article-title":"The CD6\/ALCAM pathway promotes lupus nephritis via T cell-mediated responses","volume":"132","author":"Chalmers","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107525_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107525_bib13","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/0961203316646861","article-title":"Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients","volume":"25","author":"Ma","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.phrs.2024.107525_bib14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1681\/ASN.0000000000000116","article-title":"Transcriptional and clonal characterization of cytotoxic T cells in crescentic glomerulonephritis","volume":"34","author":"Mueller","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2024.107525_bib15","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.4049\/jimmunol.1003010","article-title":"A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis","volume":"186","author":"Bethunaickan","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107525_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152731","article-title":"Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8+ T cell antitumor immunity","volume":"7","author":"Pham","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2024.107525_bib17","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.180.3.1938","article-title":"Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis","volume":"180","author":"Schiffer","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107525_bib18","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.1601565","article-title":"Dependence of glomerulonephritis induction on novel intraglomerular alternatively activated bone marrow-derived macrophages and Mac-1 and PD-L1 in lupus-prone NZM2328 mice","volume":"198","author":"Sung","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107525_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1523-1755.2001.00492.x","article-title":"Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages","volume":"59","author":"Hill","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.phrs.2024.107525_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/cei.13218","article-title":"Blocking of YY1 reduce neutrophil infiltration by inhibiting IL-8 production via the PI3K-Akt-mTOR signaling pathway in rheumatoid arthritis","volume":"195","author":"Lin","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.phrs.2024.107525_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbrc.2018.05.159","article-title":"YY1 promotes IL-6 expression in LPS-stimulated BV2 microglial cells by interacting with p65 to promote transcriptional activation of IL-6","volume":"502","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2024.107525_bib22","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.3390\/ijms23042156","article-title":"EMBER-embedding multiple molecular fingerprints for virtual screening","volume":"23","author":"Mendolia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107525_bib23","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.phrs.2024.107525_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13075-024-03292-y","article-title":"LATS2 degradation promoted fibrosis damage and rescued by vitamin K3 in lupus nephritis","volume":"26","author":"Cheng","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2024.107525_bib25","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.jid.2021.04.030","article-title":"Gene expression profiling in the skin reveals strong similarities between subacute and chronic cutaneous lupus that are distinct from lupus nephritis","volume":"141","author":"Ko","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.phrs.2024.107525_bib26","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1096\/fj.202000546R","article-title":"Betulinic acid improves nonalcoholic fatty liver disease through YY1\/FAS signaling pathway","volume":"34","author":"Mu","year":"2020","journal-title":"Faseb J."},{"key":"10.1016\/j.phrs.2024.107525_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.phrs.2024.107525_bib28","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1021\/jm010548w","article-title":"Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B","volume":"45","author":"Doman","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107525_bib29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4155\/fmc-2019-0307","article-title":"An overview of drug discovery and development","volume":"12","author":"Berdigaliyev","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.phrs.2024.107525_bib30","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jid.2019.07.699","article-title":"Research techniques made simple: an introduction to drug discovery for dermatology","volume":"139","author":"Bell","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.phrs.2024.107525_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-0716-2855-3_7","article-title":"Computer-aided drug design: an update","volume":"2601","author":"Yu","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2024.107525_bib32","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41401-023-01055-0","article-title":"Inhibiting the transcription and replication of Ebola viruses by disrupting the nucleoprotein and VP30 protein interaction with small molecules","volume":"44","author":"Ma","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2024.107525_bib33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.talanta.2012.07.019","article-title":"SPR evaluation of binding kinetics and affinity study of modified RNA aptamers towards small molecules","volume":"99","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"2012","journal-title":"Talanta"},{"key":"10.1016\/j.phrs.2024.107525_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12916-022-02436-8","article-title":"High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth","volume":"20","author":"Wang","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.phrs.2024.107525_bib35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1021\/acs.jmedchem.2c01625","article-title":"Optical-controlled kinetic switch: Fine-tuning of the residence time of an antagonist binding to the vasopressin V2 receptor in in vitro, ex vivo, and in vivo models of ADPKD","volume":"66","author":"Gu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107525_bib36","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1021\/acs.jmedchem.2c00567","article-title":"Benzodiazepine derivatives as potent vasopressin V2 receptor antagonists for the treatment of autosomal dominant kidney disease","volume":"65","author":"Cao","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107525_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"Brevini","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107525_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154659","article-title":"YY1 was indispensable for the alleviation of quercetin on diabetic nephropathy-associated tubulointerstitial inflammation","volume":"111","author":"Yang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2024.107525_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s12033-024-01093-x","article-title":"YY1 contributes to the inflammatory responses of mycobacterium tuberculosis-infected macrophages through transcription activation-mediated upregulation TLR4","author":"Yang","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.phrs.2024.107525_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pcn.13510","article-title":"YY1 (Yin-Yang 1), a transcription factor regulating systemic inflammation, is involved in cognitive impairment of depression","volume":"77","author":"Lu","year":"2023","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.phrs.2024.107525_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/bs.mie.2019.04.023","article-title":"An SPR-based analysis of cGAS substrate KD and steady-state KM values","volume":"625","author":"Ralph","year":"2019","journal-title":"Methods Enzym."},{"key":"10.1016\/j.phrs.2024.107525_bib42","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0961203312437438","article-title":"Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis","volume":"21","author":"Matar","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.phrs.2024.107525_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171350","article-title":"NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression","volume":"133","author":"Tsao","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107525_bib44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2024.107525_bib45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-0037-1607451","article-title":"Multifunctional YY1 in liver diseases","volume":"37","author":"Zhang","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.phrs.2024.107525_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba3613","article-title":"Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2024.107525_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2020-218338","article-title":"Proteomic, biomechanical and functional analyses define neutrophil heterogeneity in systemic lupus erythematosus","volume":"80","author":"Bashant","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2024.107525_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08916934.2018.1442828","article-title":"Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis","volume":"51","author":"Dos Santos","year":"2018","journal-title":"Autoimmunity"},{"key":"10.1016\/j.phrs.2024.107525_bib49","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.40863","article-title":"Pim-1 as a therapeutic target in lupus nephritis","volume":"71","author":"Fu","year":"2019","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.phrs.2024.107525_bib50","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/dom.14413","article-title":"Distribution patterns of intramyocellular and extramyocellular fat by magnetic resonance imaging in subjects with diabetes, prediabetes and normoglycaemic controls","volume":"23","author":"Kiefer","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2024.107525_bib51","article-title":"Regulatory T cell function in autoimmune disease","volume":"4","author":"Rajendeeran","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.phrs.2024.107525_bib52","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1681\/ASN.2019090937","article-title":"Lipocalin-2 exacerbates lupus nephritis by promoting Th1 cell differentiation","volume":"31","author":"Chen","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2024.107525_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149985","article-title":"YY1 regulation by miR-124-3p promotes Th17 cell pathogenicity through interaction with T-bet in rheumatoid arthritis","volume":"6","author":"Lin","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2024.107525_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw2262","article-title":"TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity","volume":"5","author":"Harbour","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phrs.2024.107525_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114434","article-title":"Paeoniflorin ameliorates murine lupus nephritis by increasing CD4+ Foxp3+ Treg cells via enhancing mTNF\u03b1-TNFR2 pathway","volume":"185","author":"Liang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107525_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2016.10.008","article-title":"A critical role of transcription factor YY1 in rheumatoid arthritis by regulation of interleukin-6","volume":"77","author":"Lin","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.phrs.2024.107525_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102898","article-title":"Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis","volume":"20","author":"Ruiz-Irastorza","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2024.107525_bib58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/0019-5154.117298","article-title":"Rebamipide: a novel agent in the treatment of recurrent aphthous ulcer and behcet's syndrome","volume":"58","author":"Kudur","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.phrs.2024.107525_bib59","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.2147\/IJN.S220754","article-title":"Co-delivery of dihydroartemisinin and HMGB1 siRNA by TAT-modified cationic liposomes through the TLR4 signaling pathway for treatment of lupus nephritis","volume":"14","author":"Diao","year":"2019","journal-title":"Int. J. Nanomed."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:49:19Z","timestamp":1734522559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824004705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"alternative-id":["S1043661824004705"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107525","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonising Yin Yang 1 ameliorates the symptoms of lupus nephritis via modulating T lymphocyte signaling","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107525"}}